Table 5 The relationship between stage, the GPS and the 12-month cancer-specific survival rate in patients with inoperable gastro-oesophageal cancer receiving active treatment (n=195)

From: Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer

 

Stage I+II

Stage III+IV

Stage I–IV

GPS 0

67% (n=31)

57% (n=47)

61% (n=78)

GPS 1

60% (n=10)

25% (n=79)

29% (n=89)

GPS 2

0% (n=6)

12 % (n=22)

16% (n=28)

GPS 0–2

62% (n=47)

33% (n=148)

40% (n=195)

  1. GPS=Glasgow Prognostic score.
Back to article page